Evidence map›Paper›PMID 41953730›Full record

ArticleJournal of veterinary research2026

Use of ELISA to predict high

Věra Fichtelová, Alena Králová, Vladimír Babák, Kamil Kovařčík

Abstract read
In one paragraph

Article in Journal of veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Věra FichtelováDepartment of Infectious Diseases and Preventive Medicine, Department of Microbiology and Antimicrobial Resistance, Veterinary Research Institute, 621 00, Brno, Czech Republic.ORCID https://orcid.org/0009-0007-9232-5345
Alena KrálováDepartment of Infectious Diseases and Preventive Medicine, Department of Microbiology and Antimicrobial Resistance, Veterinary Research Institute, 621 00, Brno, Czech Republic.ORCID https://orcid.org/0009-0006-9815-7189
Vladimír BabákDepartment of Microbiology and Antimicrobial Resistance, Veterinary Research Institute, 621 00 Brno, Czech Republic.ORCID https://orcid.org/0000-0002-0826-1075
Kamil KovařčíkDepartment of Infectious Diseases and Preventive Medicine, Department of Microbiology and Antimicrobial Resistance, Veterinary Research Institute, 621 00, Brno, Czech Republic.ORCID https://orcid.org/0009-0009-8216-8870

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Paratuberculosis is a chronic wasting disease caused by Material and Methods: A total of 139 serum and stool samples were tested. The sample-to-positive ratio (S/P) of the ELISA assay and the crossing point (Cp) of the qPCR test were used to estimate the relative amount of antibodies in serum and MAP in stool, respectively. Spearman's correlation was used to assess the relationship between S/P and Cp values. Further analyses tested the significance of differences in S/P ratios between groups of animals categorised by their level of MAP shedding. Results: A weak-to-moderate correlation was found between S/P and Cp values (rs = -0.3471). Significant differences in S/P ratios were identified between groups of animals representing moderate-to-high and low MAP shedding. High MAP shedding was associated with an S/P ≥ 2.5. Conclusion: Our findings indicate that the ELISA test can be used to predict high MAP shedding. Despite the weak-to-moderate correlation between S/P and MAP levels in faeces, animals with an S/P ≥ 2.5 should be considered high shedders and removed from the herd without delay.

Indexed as

faecal samplesJohne’s diseaseMAP sheddingparatuberculosisqPCR

Identifiers

PMID41953730
PMCPMC13054755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.